We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current VIGL market cap is 66.63M. The company's latest EPS is USD -2.0215 and P/E is -0.81.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -22.32M | -23.86M | -21.42M | -22.48M | -20.68M |
| Net Income | -20.5M | -22.17M | -19.94M | -21.23M | -19.26M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -27.21M | -42.41M | -68.88M | -88.87M |
| Net Income | -28.55M | -43.28M | -68.31M | -82.64M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 159.16M | 140.86M | 125.08M | 108.46M | 131.27M |
| Total Liabilities | 23.32M | 24.61M | 21.3M | 23.19M | 42.72M |
| Total Equity | 135.84M | 116.25M | 103.78M | 85.27M | 88.55M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 25.3M | 102.44M | 200.39M | 140.86M |
| Total Liabilities | 6.55M | 9.95M | 11.31M | 24.61M |
| Total Equity | -28.28M | -69.44M | 189.08M | 116.25M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -54.85M | -70.36M | -21.88M | -37.38M | -33.08M |
| Investing | -75.79M | -65.14M | 16.47M | 17.51M | 932k |
| Financing | 835k | 888k | 5.18M | 5.19M | 25.05M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -5.18M | -39.35M | -65.15M | -70.36M |
| Investing | -500k | -204k | -921k | -65.14M |
| Financing | 29.83M | 107.75M | 161.26M | 888k |
| Market Cap | 66.63M |
| Price to Earnings Ratio | -0.81 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.28 |
| Price to Book Ratio | 0.57 |
| Dividend Yield | - |
| Shares Outstanding | 40.88M |
| Average Volume (1 week) | 504.46k |
| Average Volume (1 Month) | 425.01k |
| 52 Week Change | -55.34% |
| 52 Week High | 6.06 |
| 52 Week Low | 1.54 |
| Spread (Intraday) | 0.27 (14.59%) |
| Company Name | Vigil Neuroscience Inc |
| Address |
850 new burton road dover, delaware 19904 |
| Website | https://www.vigilneuro.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
